CY1119957T1 - Θεραπεια νοσηματων με τη χρηση ανοχογονου φαρμακευτικου παρασκευασματος - Google Patents

Θεραπεια νοσηματων με τη χρηση ανοχογονου φαρμακευτικου παρασκευασματος

Info

Publication number
CY1119957T1
CY1119957T1 CY20181100232T CY181100232T CY1119957T1 CY 1119957 T1 CY1119957 T1 CY 1119957T1 CY 20181100232 T CY20181100232 T CY 20181100232T CY 181100232 T CY181100232 T CY 181100232T CY 1119957 T1 CY1119957 T1 CY 1119957T1
Authority
CY
Cyprus
Prior art keywords
treatment
announced
patients
pharmaceutical preparation
preparations
Prior art date
Application number
CY20181100232T
Other languages
English (en)
Inventor
Sylvain PERRUCHE
Philippe SAAS
Francis Bonnefoy
Original Assignee
Institut National De La Santé Et De La Recherche Médicale (Inserm)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National De La Santé Et De La Recherche Médicale (Inserm) filed Critical Institut National De La Santé Et De La Recherche Médicale (Inserm)
Publication of CY1119957T1 publication Critical patent/CY1119957T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/15—Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K4/00—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • C07K4/12—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof from animals; from humans

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Η παρούσα εφεύρεση αφορά φαρμακευτικά παρασκευάσματα για την αντιμετώπιση νοσημάτων τα οποία χαρακτηρίζονται από παθολογική ανοσοαπάντηση, μεθόδους θεραπείας με τη χρήση τέτοιων παρασκευασμάτων και διαδικασίες για την παρασκευή των προαναφερόμενων φαρμακευτικών παρασκευασμάτων.
CY20181100232T 2013-01-07 2018-02-27 Θεραπεια νοσηματων με τη χρηση ανοχογονου φαρμακευτικου παρασκευασματος CY1119957T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13305009 2013-01-07
PCT/EP2014/050167 WO2014106666A1 (en) 2013-01-07 2014-01-07 Disease therapy using a tolerogenic pharmaceutical preparation
EP14700238.0A EP2941257B1 (en) 2013-01-07 2014-01-07 Disease therapy using a tolerogenic pharmaceutical preparation

Publications (1)

Publication Number Publication Date
CY1119957T1 true CY1119957T1 (el) 2018-12-12

Family

ID=47559360

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20181100232T CY1119957T1 (el) 2013-01-07 2018-02-27 Θεραπεια νοσηματων με τη χρηση ανοχογονου φαρμακευτικου παρασκευασματος

Country Status (14)

Country Link
US (2) US10653758B2 (el)
EP (1) EP2941257B1 (el)
CY (1) CY1119957T1 (el)
DK (1) DK2941257T3 (el)
ES (1) ES2657675T3 (el)
HR (1) HRP20180359T1 (el)
HU (1) HUE038211T2 (el)
LT (1) LT2941257T (el)
NO (1) NO2941257T3 (el)
PL (1) PL2941257T3 (el)
PT (1) PT2941257T (el)
RS (1) RS56906B1 (el)
SI (1) SI2941257T1 (el)
WO (1) WO2014106666A1 (el)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20170117450A (ko) 2015-02-18 2017-10-23 엔리벡스 테라퓨틱스 리미티드 암 치료를 위한 면역 요법 및 사이토카인 조절 요법의 조합
US11304976B2 (en) 2015-02-18 2022-04-19 Enlivex Therapeutics Ltd Combination immune therapy and cytokine control therapy for cancer treatment
US11000548B2 (en) 2015-02-18 2021-05-11 Enlivex Therapeutics Ltd Combination immune therapy and cytokine control therapy for cancer treatment
US11318163B2 (en) 2015-02-18 2022-05-03 Enlivex Therapeutics Ltd Combination immune therapy and cytokine control therapy for cancer treatment
US11596652B2 (en) 2015-02-18 2023-03-07 Enlivex Therapeutics R&D Ltd Early apoptotic cells for use in treating sepsis
US11497767B2 (en) 2015-02-18 2022-11-15 Enlivex Therapeutics R&D Ltd Combination immune therapy and cytokine control therapy for cancer treatment
WO2016170541A1 (en) 2015-04-21 2016-10-27 Enlivex Therapeutics Ltd. Therapeutic pooled blood apoptotic cell preparations and uses thereof
KR20180110141A (ko) * 2016-02-18 2018-10-08 엔리벡스 테라퓨틱스 리미티드 암을 치료하기 위한 면역요법과 사이토카인 조절 요법의 조합
FR3082730B1 (fr) * 2018-06-21 2022-04-22 Med Inn Pharma Methode de resolution de l'inflammation pro-tumorale a l'aide d'une preparation pharmaceutique

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050202098A1 (en) 2001-01-31 2005-09-15 Tolaren Disease therapy using dying or dead cells
US20090263421A1 (en) 2005-05-10 2009-10-22 Anna-Lena Spetz-Holmgren Cellular vaccine
US9492518B2 (en) * 2006-10-04 2016-11-15 Dana-Farber Cancer Institute, Inc. Tumor immunity
EP2201954A1 (en) 2008-12-18 2010-06-30 Aposcience AG Pharmaceutical preparation

Also Published As

Publication number Publication date
HUE038211T2 (hu) 2018-10-29
WO2014106666A1 (en) 2014-07-10
LT2941257T (lt) 2018-02-26
EP2941257B1 (en) 2017-11-29
US10653758B2 (en) 2020-05-19
US20150343039A1 (en) 2015-12-03
DK2941257T3 (en) 2018-02-26
ES2657675T3 (es) 2018-03-06
US20200237884A1 (en) 2020-07-30
EP2941257A1 (en) 2015-11-11
HRP20180359T1 (hr) 2018-05-04
NO2941257T3 (el) 2018-04-28
US11793865B2 (en) 2023-10-24
PL2941257T3 (pl) 2018-05-30
PT2941257T (pt) 2018-03-06
RS56906B1 (sr) 2018-05-31
SI2941257T1 (en) 2018-03-30

Similar Documents

Publication Publication Date Title
CY1119957T1 (el) Θεραπεια νοσηματων με τη χρηση ανοχογονου φαρμακευτικου παρασκευασματος
CY1123845T1 (el) Τοπικα φαρμακευτικα σκευασματα για την αγωγη φλεγμονωδων καταστασεων
CY1124436T1 (el) Δικυκλικες ετεροκυκλικες ενωσεις και χρησεις αυτων στη θεραπεια
CY1120862T1 (el) Παραγοντες επαγωγης αποπτωσης για τη θεραπευτικη αγωγη καρκινου και ανοσων και αυτοανοσων ασθενειων
CY1119058T1 (el) Ενωσεις ιμιδαζοπυρρολιδινονης
EA201891186A1 (ru) Антитела, нейтрализующие вирус иммунодефицита человека
CY1121736T1 (el) Άλατα aramchol
EA201890204A1 (ru) Антибактериальные соединения
EA201590343A1 (ru) Алкилпиримидиновые производные для лечения вирусных инфекций и дальнейших заболеваний
EA201691582A1 (ru) Новые фармацевтические препараты
UA116648C2 (uk) Фумарати як проліки та їх застосування при лікуванні різних захворювань
EA201500207A1 (ru) Гетероароматические соединения в качестве ингибиторов втк
EA201590667A1 (ru) Ациламинопиримидиновые производные для лечения вирусных инфекций и других заболеваний
EA201591887A1 (ru) Макроциклические деазаоксипурины для лечения вирусных инфекций
EA201790273A1 (ru) Флагеллиновые композиции и их применение
EA201500383A1 (ru) Производные 1,2,4-триазина для лечения вирусных инфекций
EA201692043A1 (ru) Лекарственная форма иммунодепрессанта
BR112017000898A2 (pt) oritavancina de alta pureza e método de produção da mesma
CY1121105T1 (el) Φαρμακοτεχνικη μορφη αταζαναβιρης και κομπισιστατης για θεραπεια hiv
EA201792571A1 (ru) Терапевтическое применение l-4-хлорокинуренина
MX364528B (es) Witanólidos útiles para el tratamiento de enfermedades neurodegenerativas.
CL2015003431A1 (es) Derivados de piridona para el tratamiento de infecciones virales y enfermedades adicionales
CY1122708T1 (el) Ενωσεις οξα-διαζασπειρο με δραση εναντι του πονου
MD20180049A2 (ro) Compoziţie farmaceutică
CY1120192T1 (el) Ενωσεις για την ενισχυση της γνωστικης λειτουργιας